N
44.56
-2.43 (-5.17%)
| Penutupan Terdahulu | 46.99 |
| Jumlah Dagangan | 1,472,286 |
| Harga / Jualan (P/S) | 25.68 |
| Harga / Buku (P/B) | 2.18 |
| Julat 52 Minggu |
| Margin Keuntungan | -152.49% |
| Margin Operasi (TTM) | -424.15% |
| EPS Cair (TTM) | -9.45 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -51.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 1,358.71% |
| Nisbah Semasa (MRQ) | 3.24 |
| Aliran Tunai Operasi (OCF TTM) | -176.87 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -47.84 M |
| Pulangan Atas Aset (ROA TTM) | -26.80% |
| Pulangan Atas Ekuiti (ROE TTM) | -189.46% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Nektar Therapeutics | Bercampur | Menaik |
AISkor Stockmoo
0.8
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | 3.0 |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Purata | 0.75 |
|
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 1.29% |
| % Dimiliki oleh Institusi | 67.11% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Two Seas Capital Lp | 30 Jun 2026 | 3,092,234 |
| Prosight Management, Lp | 30 Jun 2026 | 810,000 |
| Armistice Capital, Llc | 30 Jun 2026 | 724,000 |
| Gilder Gagnon Howe & Co Llc | 30 Jun 2026 | 600,873 |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| AJER JEFFREY ROBERT | 57.66 | - | 2,000 | 115,320 |
| BRAINARD DIANA | 57.66 | - | 2,000 | 115,320 |
| CHESS ROBERT | 57.66 | - | 2,000 | 115,320 |
| GREER R SCOTT | 57.66 | - | 2,000 | 115,320 |
| WHITFIELD ROY A | 57.66 | - | 2,000 | 115,320 |
| Jumlah Keseluruhan Kuantiti Bersih | 10,000 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | 576,600 | |||
| Purata Pembelian Keseluruhan ($) | 57.66 | |||
| Purata Jualan Keseluruhan ($) | - | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| AJER JEFFREY ROBERT | Pengarah | 23 Sep 2026 | Diperolehi (+) | 2,000 | 57.66 | 115,320 |
| BRAINARD DIANA | Pengarah | 23 Sep 2026 | Diperolehi (+) | 2,000 | 57.66 | 115,320 |
| CHESS ROBERT | Pengarah | 23 Sep 2026 | Diperolehi (+) | 2,000 | 57.66 | 115,320 |
| GREER R SCOTT | Pengarah | 23 Sep 2026 | Diperolehi (+) | 2,000 | 57.66 | 115,320 |
| WHITFIELD ROY A | Pengarah | 23 Sep 2026 | Diperolehi (+) | 2,000 | 57.66 | 115,320 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |